Abstract:Introduction: Alzheimer's disease (AD) and epilepsy are reciprocally related. Among sporadic AD patients, clinical seizures occur in 10–22% and subclinical epileptiform abnormalities occur in 22–54%. Cognitive deficits, especially short-term memory impairments, occur in most epilepsy patients. Common neurophysiological and molecular mechanisms occur in AD and epilepsy. The choroid plexus undergoes pathological changes in aging, AD, and epilepsy, including decreased CSF turnover, amyloid beta (Aβ), and tau accumulation due to impaired clearance and disrupted CSF amino acid homeostasis. This pathology may contribute to synaptic dysfunction in AD and epilepsy. Methods: We evaluated control ( n = 8), severe AD ( n = 8; A3, B3, C3 neuropathology), and epilepsy autopsy cases ( n = 12) using laser capture microdissection (LCM) followed by label-free quantitative mass spectrometry on the choroid plexus adjacent to the hippocampus at the lateral geniculate nucleus level. Results: Proteomics identified 2,459 proteins in the choroid plexus. At a 5% false discovery rate (FDR), 616 proteins were differentially expressed in AD vs. control, 1 protein in epilepsy vs. control, and 438 proteins in AD vs. epilepsy. There was more variability in the epilepsy group across syndromes. The top 20 signaling pathways associated with differentially expressed proteins in AD vs. control included cell metabolism pathways; activated fatty acid beta-oxidation ( p = 2.00 x 10 −7 , z = 3.00), and inhibited glycolysis ( p = 1.00 x 10 −12 , z = −3.46). For AD vs. epilepsy, the altered pathways included cell metabolism pathways, activated complement system ( p = 5.62 x 10 −5 , z = 2.00), and pathogen-induced cytokine storm ( p = 2.19 x 10 −2 , z = 3.61). Of the 617 altered proteins in AD and epilepsy vs. controls, 497 (81%) were positively correlated ( p < 0.0001, R 2 = 0.27). Discussion: We found altered signaling pathways in the choroid plexus of severe AD cases and many correlated changes in the protein expression of cell metabolism pathways in AD and epilepsy cases. The shared molecular mechanisms should be investigated further to distinguish primary pathogenic changes from the secondary ones. These mechanisms could inform novel therapeutic strategies to prevent disease progression or restore normal function. A focus on dual-diagnosed AD/epilepsy cases, specific epilepsy syndromes, such as temporal lobe epilepsy, and changes across different severity levels in AD and epilepsy would add to our understanding.

Untargeted metabolomics profiling in pediatric patients and adult populations indicates a connection between lipid imbalance and epilepsy

Metabolite Associations with Childhood and Juvenile Absence Epilepsy: A Bidirectional Mendelian Randomization Study

Integrative analysis of non-targeted lipidomic data and brain structural imaging identifies phosphatidylethanolamine associated with epileptogenesis

Quantitative proteomic analysis to identify differentially expressed proteins in patients with epilepsy

Proteomic Differences in the Hippocampus and Cortex of Epilepsy Brain Tissue

Integrating metabolomics and lipidomics revealed a decrease in plasma fatty acids but an increase in triglycerides in children with drug-refractory epilepsy

Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry

Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study

Alterations in serum metabolomics during the first seizure and after effective control of epilepsy

Integrated Macrogenomics and Metabolomics Explore Alterations and Correlation between Gut Microbiota and Serum Metabolites in Adult Epileptic Patients: A Pilot Study

Lipid metabolism: Novel approaches for managing idiopathic epilepsy

Metabonomic analysis of cerebrospinal fluid in epilepsy

Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review

Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients

Identification of Adipocytokine Pathway-Related Genes in Epilepsy and Its Effect on the Peripheral Immune Landscape

Glucose Metabolic Profile by Visual Assessment Combined with Statistical Parametric Mapping Analysis in Pediatric Patients with Epilepsy.

Metabolic epilepsies: approaches to a diagnostic challenge

Estimating the likelihood of epilepsy from clinically noncontributory electroencephalograms using computational analysis: A retrospective, multisite case–control study

A deep learning framework for 18 F-FDG PET imaging diagnosis in pediatric patients with temporal lobe epilepsy

Epilepsy: Mitochondrial connections to the 'Sacred' disease

Analyzing the causal relationship between lipid-lowering drug target genes and epilepsy: a Mendelian randomization study